Market Overview

Benzinga's Top Downgrades

Share:
Related PRXL
Jefferies Previews Booming Biotech Earnings
Deutsche Bank's Top 20 'Best Buy Ideas'
Parexel updates guidance for FQ4 and FY2015 (Seeking Alpha)
Related MT
Analyst Sees Steel-Dumping Case On Horizon, Launches Sector Coverage
Clarkson Capital Markets Initiates On Metals & Miners

Analysts at Jefferies downgraded PAREXEL International (NASDAQ: PRXL) from “buy” to “hold.” PAREXEL's shares closed at $32.38 yesterday. PAREXEL's trailing-twelve-month ROA is 4.01%.

Analysts at Citigroup downgraded ArcelorMittal (NYSE: MT) from “buy” to “neutral.” ArcelorMittal's shares closed at $14.65 yesterday. ArcelorMittal's trailing-twelve-month profit margin is 0.69%.

Analysts at Goldman Sachs downgraded MeadWestvaco (NYSE: MWV) from “buy” to “neutral.” MeadWestvaco's shares closed at $31.20 yesterday. MeadWestvaco's PEG ratio is 2.16.

RBC Capital downgraded Endo Health Solutions (NASDAQ: ENDP) from “outperform” to “sector perform.” Endo Health's shares closed at $31.51 yesterday. Endo Health's trailing-twelve-month ROA is 5.13%.

Latest Ratings for PRXL

DateFirmActionFromTo
Apr 2015JefferiesMaintainsHold
Mar 2015SunTrust Robinson HumphreyMaintainsNeutral
Feb 2015CitigroupMaintainsBuy

View More Analyst Ratings for PRXL
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ENDP + MT)

Around the Web, We're Loving...

Get Benzinga's Newsletters